Publications

Detailed Information

Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5

DC Field Value Language
dc.contributor.authorCha, Ran-hui-
dc.contributor.authorYang, Seung Hee-
dc.contributor.authorKim, Sun Moon-
dc.contributor.authorPark, Myoung Hee-
dc.contributor.authorKim, Hyo Sang-
dc.contributor.authorHa, Jongwon-
dc.contributor.authorKim, Yon Su-
dc.date.accessioned2012-05-24T05:00:01Z-
dc.date.available2012-05-24T05:00:01Z-
dc.date.issued2009-09-
dc.identifier.citationNEPHROLOGY DIALYSIS TRANSPLANTATION; Vol.24 9; 2919-2925ko_KR
dc.identifier.issn0931-0509-
dc.identifier.urihttps://hdl.handle.net/10371/76401-
dc.description.abstractBackground. Acute rejection (AR) contributes to the development of chronic allograft nephropathy that is the major cause of graft failure. We analyzed the 59029G>A polymorphism and an internal 32 bp deletion (CCR5 32) of CCR chemokine receptor 5 (CCR5) and tried to prove the hypothesis that genetic interactions between the donor
and the recipient influence the development of AR. Methods. We detected genetic polymorphisms by the TaqMan (R) method and by sizing PCR amplicons (n = 486). The primary outcomes were early acute rejection (EAR) and repeated early acute rejection (RR). We defined EAR as the occurrence of a biopsy-proven AR within 3 months after transplantation. Results. The development of EAR was dependent on the number of A alleles in recipients and showed a dose-response relationship (P = 0.002). When we combined the number of A alleles in both donor and recipient, episodes of EAR and RR were more prevalent as the allelic number increased (A allelic number 0 & 1, 2 versus 3 & 4, P = 0.048; 0 & 1 versus 3 & 4, P = 0.006). Statistical significance was preserved after multivariate analysis of sex, HLA mismatch and type of donor with the recipient`s age as the continuous term. Also, graft survival was different according to the presence of the A allele, i.e. recipients carrying A allele (+) grafts showed poor graft survival (P = 0.008 by a log-rank test). Again, the number of A alleles affected graft survival as the recipients who carried more A alleles had poor graft survival (A allele number 0 & 1 versus 2 versus 3 & 4, P = 0.011; 0 & 1 versus 3 & 4, P = 0.08; 0 & 1 versus 2, P = 0.002; by a log-rank test). All of the participants were wild-type homozygotes for CCR5 delta 32. Conclusions. The A allele of CCR5 59029G > A was a risk factor for EAR and RR. As the number of A alleles increased, episodes of EAR were more frequently observed.
ko_KR
dc.description.sponsorshipThis study was supported by a grant from the Korea
Health 21 R & D project, Ministry of Health and Welfare, Republic of
Korea (03-PJ10-PG13-GD01-0002).
ko_KR
dc.language.isoenko_KR
dc.publisherOXFORD UNIV PRESSko_KR
dc.subjectacute rejectionko_KR
dc.subjectCCR5ko_KR
dc.subjectkidney transplantationko_KR
dc.subjectpolymorphismko_KR
dc.titleGenetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5ko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor차란휘-
dc.contributor.AlternativeAuthor김연수-
dc.contributor.AlternativeAuthor양승희-
dc.contributor.AlternativeAuthor김선문-
dc.contributor.AlternativeAuthor박명희-
dc.contributor.AlternativeAuthor하종원-
dc.contributor.AlternativeAuthor김효상-
dc.identifier.doi10.1093/ndt/gfp317-
dc.citation.journaltitleNEPHROLOGY DIALYSIS TRANSPLANTATION-
dc.description.citedreferenceThio CL, 2008, J IMMUNOL, V181, P7944-
dc.description.citedreferenceWang F, 2008, SCHIZOPHR RES, V101, P341, DOI 10.1016/j.schres.2008.01.015-
dc.description.citedreferenceBerce V, 2008, J ASTHMA, V45, P780, DOI 10.1080/02770900802386024-
dc.description.citedreferenceTakacova M, 2008, ACTA VIROL, V52, P261-
dc.description.citedreferenceYigit B, 2007, CELL BIOCHEM FUNCT, V25, P423, DOI 10.1027/cbf.1322-
dc.description.citedreferenceAhn SH, 2006, J MED VIROL, V78, P1564, DOI 10.1002/jmv.20739-
dc.description.citedreferencePrahalad S, 2006, GENES IMMUN, V7, P468, DOI 10.1038/sj.gene.6364317-
dc.description.citedreferenceNankivell BJ, 2006, TRANSPLANTATION, V81, P643, DOI 10.1097/01.tp.0000190423.82154.01-
dc.description.citedreferenceMarin LA, 2006, TISSUE ANTIGENS, V67, P117, DOI 10.1111/j.1399-0039.2005.00538.x-
dc.description.citedreferenceSimeoni E, 2005, TRANSPLANTATION, V80, P1309, DOI 10.1097/01.tp.0000178378.53616.ca-
dc.description.citedreferenceLacha J, 2005, TRANSPLANT P, V37, P764, DOI 10.1016/j.transproceed.2004.12.224-
dc.description.citedreferenceABUL KA, 2005, CELLULAR MOL IMMUNOL, P375-
dc.description.citedreferenceHoffmann S, 2004, KIDNEY INT, V66, P1686-
dc.description.citedreferenceFernandez-Mestre MT, 2004, HUM IMMUNOL, V65, P725, DOI 10.1016/j.humimm.2004.05.002-
dc.description.citedreferenceRuster M, 2004, CLIN NEPHROL, V61, P30-
dc.description.citedreferenceCLARK VJ, 2004, HUM GENOMICS, V1, P255-
dc.description.citedreferenceNakajima K, 2003, DIABETES CARE, V26, P892-
dc.description.citedreferenceSchroppel B, 2002, J CLIN IMMUNOL, V22, P381-
dc.description.citedreferenceEl-Sawy T, 2002, CURR OPIN IMMUNOL, V14, P562-
dc.description.citedreferenceKeen LJ, 2002, TRANSPL IMMUNOL, V10, P143-
dc.description.citedreferenceInston NG, 2002, NEPHROL DIAL TRANSPL, V17, P1374-
dc.description.citedreferenceAbdi R, 2002, J AM SOC NEPHROL, V13-
dc.description.citedreferenceFischereder M, 2001, LANCET, V357, P1758-
dc.description.citedreferenceHancock WW, 2001, J EXP MED, V193, P975-
dc.description.citedreferenceHancock WW, 2000, CURR OPIN IMMUNOL, V12, P511-
dc.description.citedreferenceGrone HJ, 1999, FASEB J, V13, P1371-
dc.description.citedreferenceSchlondorff D, 1997, KIDNEY INT, V51, P610-
dc.description.citedreferenceNaruse K, 1996, GENOMICS, V34, P236-
dc.description.tc9-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share